Proethos Fond vs UBS Lux Equity Fund Biotech USD

Proethos Fond vs UBS Lux Equity Fund Biotech USD

1. Proethos Fond

  • Security

    Proethos Fond

  • Fee

    0.65%

  • ISIN

    SE0010547778

  • Holdings

    6

  • Number of owning funds

    1

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 9 holdings in Proethos Fond, where the largest holding is Vestas (5.81), followed by Ormat Technologies (4.45) and First Solar (4.38). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Proethos Fond and UBS Lux Equity Fund Biotech USD.

Proethos Fond UBS Lux Equity Fund Biotech USD
1. Vestas Wind Systems A/S
Denmark
5.81 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Ormat Technologies Inc
USA
4.45 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. First Solar Inc
USA
4.38 %
3. Moderna Inc
9.21 %
4. NIBE Industrier B
Sweden
4.3 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Nordex SE
Germany
3.93 %
5. AbbVie Inc
USA
5.52 %
6. Enphase Energy Inc
USA
2.45 %
6. Gilead Sciences Inc
USA
4.66 %
- 7. Amgen Inc
4.32 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.28 %

The list of fund holdings was last updated on April 17, 2025.